Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-014965
Filing Date
2020-06-02
Accepted
2020-06-02 21:00:32
Documents
2
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4781
2 EX-24 DOCUMENT attachment1.htm EX-24 4755
  Complete submission text file 0000899243-20-014965.txt   10922
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
HOMCY CHARLES J (Reporting) CIK: 0001192591 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39303 | Film No.: 20938719

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations